Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2003
06/19/2003US20030114666 Antibacterial agents
06/19/2003US20030114471 Anticancer agent
06/19/2003US20030114468 Psychological disorders
06/19/2003US20030114467 Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof
06/19/2003US20030114458 Antibacterial agents
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114422 Thrombosis, brain disorders, cardiovascular disorders, Alzheimer's disease, Huntington diseases
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030111108 Convergent synthesis of multiporphyrin light-harvesting rods
06/19/2003CA2469613A1 Process for affecting neurologic progression
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467916A1 Mitotic kinesin inhibitors
06/18/2003EP1319975A1 Synthesis of peptoid substituted azole compounds
06/18/2003EP1319661A1 Process for producing tricyclic fused heterocyclic derivative
06/18/2003EP1319255A1 Light harvesting arrays
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319006A1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
06/18/2003EP1319005A2 Substituted azepino[4,5-b]indoline derivatives
06/18/2003EP1319004A2 Substituted azepino[4,5-b]indole derivatives
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318815A2 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003EP0934943B1 Process for the preparation of acylated hexaazaisowurtzitane derivatives
06/18/2003CN1425015A Chlorophyll and bacteriochlorophyll esters, and their preparation
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1424938A High surface microporous active materials TIQ-6 and METIQ-6 in oxidation reactions
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/17/2003US6580003 Catalytic asymmetric desymmetrization of meso compounds
06/17/2003US6579894 Bactericides, fungicides
06/17/2003US6579878 Pharmaceutical compositions and methods for use
06/17/2003US6579876 Imidazo(4,5-d)pyridazines
06/17/2003US6579875 Triazolo-pyridazine derivatives as ligands for GABA receptors
06/17/2003US6579869 Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents
06/17/2003US6579632 OLEDs doped with phosphorescent compounds
06/17/2003US6579326 For dyeing hair
06/12/2003WO2003048165A1 ADENOSINE A2a RECEPTOR ANTAGONISTS
06/12/2003WO2003048164A2 Adenosine a2a receptor antagonists
06/12/2003WO2003048163A1 [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048132A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
06/12/2003WO2003048122A2 Inhibitors of cytosolic phospholipase a2
06/12/2003WO2003048120A2 2-aryl pyrrologpyrimidines for a1 and a3 receptors
06/12/2003WO2003047576A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003WO2003047505A2 Topoisomerase poison agents
06/12/2003WO2002047679A3 Nonpeptide agonists and antagonists of vasopressin receptors
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109555 Targeted drug delivery using sulfonamide derivatives
06/12/2003US20030109536 Treatment of a variety of central nervous system (CNS) disorders in humans, domesticated companion animals and livestock animals. treatment of anxiety, depression, a sleep disorder, attention deficit disorder, or Alzheimer's dementia,
06/12/2003US20030109484 Novel 2'-halomethylidene, 2'-ethenylidene and 2'ethynyl cytidine, uridine and guanosine derivatives
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003CA2469130A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003CA2468927A1 Ring fused pyrazole derivatives
06/12/2003CA2468893A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
06/11/2003EP1318151A1 Porphyrin compounds consisting of porphyrin rings fused in a single direction by three bonds, i.e., one meso-meso carbon bond and two beta-beta carbon bonds and process for their synthesis
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317446A1 Oxindole derivatives
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1181293A4 Cucurbiturils and method for synthesis
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0892787B1 Novel alpha-hydroxylic acid derivatives, their production and use
06/11/2003CN1423651A New use and novel N-azabicyclo-amide derivatives
06/10/2003US6576768 Preparation of alkylthio- and/or arylthio-substituted diketo-diaryl-pyrrolopyrroles
06/10/2003US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2120020C Air treatment plant for foodstuff comprising a trough with an adjustable width
06/10/2003CA2086404C Triazolopyrimidine derivatives
06/06/2003WO2002044181A1 Hydantoin compounds useful as anti-inflammatory agents
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045915A1 Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition
06/05/2003WO2003045906A2 Synthesis of 2-cyanoziridine-1-carboxamide
06/05/2003WO2003045334A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003008430A3 Porphyrin derivatives for photodynamic therapy
06/05/2003WO2002104072A3 Emissive multichromophoric systems
06/05/2003US20030105375 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity
06/05/2003US20030105321 Substituted phthalocyanine
06/05/2003US20030105130 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors
06/05/2003US20030105118 Tricyclic quinazolinediones
06/05/2003US20030105117 For therapy of affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, gastrointestinal diseases, anorexia
06/05/2003US20030105116 Fused tri-heterocyclic compounds
1 ... 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 ... 573